A severely affected MRL/Lpr mouse exhibits a divergent clinical-immune profile associated with a profound metabolic alteration.
Karim Matmat, Carole Jamey, Noémie Karabacz, Daniel Brumaru, Jerome De Seze, Ayikoe Guy Mensah‐Nyagan, Hélène Jeltsch‐David
The paper describes a severely affected MRL/Lpr mouse with divergent clinical-immune features and profound metabolic alterations, highlighting metabolic dysregulation as a key factor in advanced disease.
Immunology Letters · Sep 25, 2026Peer-reviewedImmunology